Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade.

We found that DNT cells expressing NKG2D and DNAM1 were present in both control and anti-PD-1 treated mice but were more abundant in mice receiving combination therapy than those receiving DNT cells alone, though differences did not reach statistical significance (Fig. 5 c).

also in 111,027 other papers